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Abstract: Among bioactive phytochemicals, ellagic acid (EA) is one of the most controversial because
its high antioxidant and cancer-preventing effects are strongly inhibited by low gastrointestinal
absorption and rapid excretion. Strategies toward an increase of solubility in water and bioavailability,
while preserving its structural integrity and warranting its controlled release at the physiological
targets, are therefore largely pursued. In this work, EA lysine salt at 1:4 molar ratio (EALYS),
exhibiting a more than 400 times increase of water solubility with respect to literature reports, was
incorporated at 10% in low methoxylated (LM) and high methoxylated (HM) pectin films. The release
of EA in PBS at pH 7.4 from both film preparations was comparable and reached 15% of the loaded
compound over 2 h. Under simulated gastric conditions, release of EA from HM and LM pectin films
was minimal at gastric pH, whereas higher concentrations—up to 300 µM, corresponding to ca. 50% of
the overall content—were obtained in the case of the HM pectin film after 2 h incubation at the slightly
alkaline pH of small intestine environment, with the enzyme and bile salt components enhancing
the release. EALYS pectin films showed a good prebiotic activity as evaluated by determination of
short chain fatty acids (SCFAs) levels following microbial fermentation, with a low but significant
increase of the effects produced by the pectins themselves. Overall, these results highlight pectin
films loaded with EALYS salt as a promising formulation to improve administration and controlled
release of the compound.
Keywords: ellagic acid lysine salt; pectin-based formulations; controlled release; gastrointestinal
digestion; gut microbiota
1. Introduction
Ellagic acid (EA)—a polyphenol widely distributed in fruits, particularly in berries,
nuts, and pomegranates—is presently the focus of high interest in the pharmacological and
nutraceutical sectors because of its many biological activities. In addition to its remarkable
antioxidant activity, its antiviral, antimicrobic [1], antiteratogenic [2], stimulation of type I
collagen production and elastin protection in skin [3], and, most importantly, antitumor ac-
tivities have been reported [4]. The latter results from an antiproliferative action combined
with the ability to exert a protective function toward DNA against carcinogenic agents
by adduct formation [5,6]. Chemopreventive and anti-inflammatory activities have been
reported for urolithins derived by catabolism of EA by gut microbiota [7–9]. Other metabo-
lites like methyl and dimethyl ethers and glucuronates are generated by EA following
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adsorption by ileum cells and have been found in the plasma, urine, and bile of animals
fed with ellagitannins [9,10]. However, EA accumulates mainly in the intestinal epithelium,
but only to a limited extent in the liver, lungs and blood [9].
The low aqueous solubility of EA and permeability in the gastrointestinal tract (GIT),
its permanent binding to DNA and proteins of cells, and first pass metabolism are consid-
ered the main reasons for its low oral bioavailability and consequently its low therapeutic
potential. In addition to low absorption in the GIT, EA is also rapidly eliminated, typically
within 2–6 h, depending on food composition [6]. In a previous work, González-Sarrías
et al. studied in vivo–in vitro human EA bioavailability, resulting in a large interindivid-
ual variability, identifying multiple key factors (low solubility of free EA under gastric
conditions, type of precursor, limited intestinal EA absorption). In addition, even upon
high free EA intake, EA concentration in plasma was always quite low [11]. It has been
demonstrated that in the grand intestine tract, EA undergoes an extensive metabolism by
the gut microbiota providing urolithins, which are 25–80-fold more bioavailable and much
better absorbed than EA [12,13]. Based on these data, interest has significantly increased in
recent years for the development of delivery systems that might increase the solubility in
water and bioavailability of EA, preserve its structural integrity, and warrant its controlled
release at the physiological target [14].
In this frame, in a recent study we have shown that EA is a main constituent (40% on
a w/w basis) of the alcoholic extracts of the wastes deriving from production of wines
by yeast fermentation of Punica granatum [15]; the fermented residues are able to slowly
release EA up to 80% of the overall content over 2 h incubation at the slightly alkaline
pH, simulating the small intestine environment. Nanosponges based on cyclodextrin and
cross-linked by dimethyl carbonate loaded with EA have been reported to improve its
solubilization and oral bioavailability in animal models [16]. Schizophyllan–chitin-based
nanoparticles have been proposed to encapsulate EA as an anticancer agent, improving
its effects [17]. However, the possibility to exploit biocompatible or natural biopolymers
that are readily available and commonly used as oral drug delivery systems for improv-
ing EA solubility and to increase its bioavailability in the gut, minimizing its release in
the upper GIT, has so far been scarcely explored. To this aim of particular interest are
pectins, a soluble dietary fiber—containing mainly partially methoxylated galacturonic
acid—that is available at low cost. Pectins are widely used in food industries (food ad-
ditive E440 according to International Numbering System for Food Additives (INS)) as
gelling or thickening agents and in the pharmaceutical industry as bulking agents in drug
production, in wound healing preparations, and in medical adhesives for oral drug deliv-
ery formulations (e.g., controlled release systems, gastro-retentive systems, colon-specific
delivery systems, and mucoadhesive delivery systems). Beads prepared from sodium
alginate and pectin with dual cross-linking were tested for effective control of release of
the antidiabetic drug repaglinide [18]. Numerous applications have been reported that
exploit the colon-specific delivery ability of pectins. These include: (a) the chitosan/layered
double hydroxide biohybrid beads coated with pectin that proved efficient for controlled
release of 5-aminosalycilic acid in the treatment of colon diseases [19]; (b) gel microspheres
by ionotropic gelation synthesized from pectins with different methylation degrees for
encapsulation of sulfasalazine, a nonsteroidal anti-inflammatory drug used mainly for the
treatment of an inflammatory bowel and other diseases [20]; and (c) calcium pectinate gel
beads for the release of prednisolone [21]. Moreover, due to the presence of highly polar
functional groups, pectins have been used for the controlled release of polyphenols. Citrus
pectin encapsulation of anthocyanins was found to increase intestinal accessibility during
passage through the small intestine in healthy volunteers [22].
In the present study, high methoxylated pectin (HM) extracted from apple and low
methoxylated pectin (LM) extracted from citrus peel were investigated for the controlled
release of EA. A salt of EA with lysine (EALYS) was prepared to improve water solubility
and loading into the pectin matrix. The release of EA from these formulations under
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simulated gastrointestinal conditions was evaluated as well as the prebiotic activity on the
gut microbiota.
2. Results and Discussion
2.1. EALYS Preparation
EA (structure reported in Figure 1) was solubilized in water in the presence of variable
amounts of lysine. The results show that only EALYS 1:4 salt is soluble in water (up to
13 mg/mL). Its 1H-NMR spectrum confirmed protonation of the amino group in lysine and
the presence of EA signal at 7.13 ppm and those from lysine at higher fields. According
to literature, the water solubility of EA is 9.7 µg/mL [23]; therefore, considering that EA
represents 34% w/w of EALYS, the water solubility of EA increased more than 400 times
thanks to the salt formation.
Figure 1. Ellagic acid (EA).
Solubility studies were also conducted using a CaCl2 water solution, since the latter
is used to obtain pectin gels, and in PBS solution (pH = 7.4), used for release tests to
mimic physiological media. The solubility of EALYS dramatically decreased when calcium
chloride was added to water, dropping to 0.31 mg/mL, i.e., less than 2.5% of the solubility
of EALYS 1:4 in pure water. Examples of limited solubility of calcium salts of phenols were
already reported [24]; therefore, the formation of a very low water-soluble calcium–EA salt
could explain the reduction of solubility of EALYS in water solution. Nevertheless, Ca2+ is
fundamental to obtaining pectin gels, as already described in previous literature [21], due
to the ion-exchanging reaction occurring with –COOH pectin groups (Figure 2).
Figure 2. (a): pectin structure. (b): Schematic interaction between calcium ions and pectin COO−
groups.
Additionally, PBS reduced the solubility of EALYS in comparison with water, leading
to a solubility of 8.95 mg/mL. This can be explained considering that phosphate ions
interfere with lysine and lead to EA partial precipitation.
In conclusion, in 1:4 EALYS, the excess of lysine permitted the solubilization of the
salt acting as a compatibilizer between water and EA–lysine diprotic salt, allowing us to
obtain for subsequent pectin film preparation a highly water-soluble form of EA that could
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be used with a final concentration of 0.31 mg/mL, more than 30 times higher than the
solubility of EA alone in water.
2.2. Optimization of Pectin Film Preparation
2.2.1. Degree of Esterification Determination
Two pectins at different degrees of esterification (DEs) were used for the preparation
of films, namely low methoxylated pectin (LM) pectin (DE ≈ 50%) and high methoxylated
pectin (HM) pectin (DE ≈ 70%). The exact DE to properly evaluate the amount of CaCl2
necessary to obtain the gels was calculated according to the procedure indicated in para-
graph 3.6 by checking the bands at ≈1601 and ≈1740 cm−1 as reported in literature [20].
Spectra of LM and HM pectins are reported in Figure 3.
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The band at ca. 1601 cm−1 is due to the symmetrical stretching vibration of carboxylate
moiety, whereas the band at ca. 1740 cm−1 is assigned to stretching of carbonyl groups
from both carboxylic acid and methyl ester moieties. Considering that at pH 6 in partially
methoxylated pectin the carboxylic groups were completely deprotonated, the 1740 cm−1
band can be attributed exclusively to the carboxymethyl groups. The ratio between the
absorbance intensity at 1740 cm−1 divided by the sum of those at 1601 and 1740 cm−1 is
proportional to DE. The equation reported by Manrique et al. [25] that correlates the DE to
absorbance parameters was used for DE determination of the pectins. According to this
method, a degree of esterification of 59.3% was determined for citrus peel pectin (LM),
whereas a degree of esterification of 70.9% (HM) was assessed for apple-based pectin.
2.2.2. Rheological Analyses
Several pectin concentrations were tested to obtain gels: frequency sweep experiments
showed th t both for HM and for LM pectin, low concentrations, i.e., 3, 5, 7.5, and 10 g/L,
led to gels having very low viscosity th t were not sufficient to provide a stable and
tough gel (data not shown). On the other side, pectin co centrations of 20 g/L and higher
led to stable and tough gel having a sto age modulus (G’) signific n ly higher than the
loss modulus (G”), with the highest pectin concentration (40 g/L) resulting in a highly
viscous gel (Figure 4). Given the results obtained, 30 g/L was chosen as the best pectin
concentration for the dev lopm nt of EALYS-cont ining gels: test were also repeated after
168 h, confirming that the gel was stable an no depolymerization of pectin occurred (see
Figure S1 in Supplementary Materials).
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Since the release of active principles can be affected by the viscosity of the gel, the
rheology of EALYS-loaded gels was checked: the presence of EALYS did not affect t e vis-
cosity of the gels immediately after the gelling period (48 h). However, after a week, at low
shear rate, the viscosity displayed an anomalous decreasing trend. This can be explained
considering that, as discussed before, EALYS shows a decreased solubility in water when
Ca2+ is present, due to the formation of EA(Ca)n(LYS)m salts. Probably, the reaction of EA
with calcium ions subtracted Ca2+ from the pectin network reducing the viscosity of gels.
Although a decrease in viscosity for shear rate lower than 0.01 s−1 was registered, the G’
modulus was still higher than the G” modulus (see Figure S2 in Supplementary Materials);
therefore, the solid structure of pectin gel was not yet compromised. This confirms that
the gel retained the solid structure even when EALYS solubility was reduced due to the
presence of calcium ions.
2.3. Release Experiments
The release of EALYS from LM + 10%EALYS and HM + 10%EALYS films were com-
pared in order to determine the effect of DE on the release properties. Both samples showed
the same behavior: the quantity of EALYS released after 120 min was very similar, i.e.,
about 15% and 17% with LM and HM pectin gels, respectively, and in both cases a plateau
was reached after 60 min (Figure 5). Additionally, HM + 2% EALYS release was assessed: a
burst release was observed, since after only 20 min 25% of EALYS was released. Plateau
was reached after about 60 min, when about 28% of EALYS was released. Although the
relative quantity of EALYS released was higher in the 2% sample, the absolute quantity
released was far higher in s mples loaded with 10% EALYS; therefore, 2% samples were
not further investigated. In any c s , rele se after 24 h was not significantly differe from
that obtained after 120 min.
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Figure 5. Release kinetics for the EA with lysine (EALYS)-loaded LM and HM pectin films in
phosphate buffered saline (PBS) at pH 7.4 at 2 w/w%. (a): Release from LM + 10% EALYS vs. HM +
10% EALYS. (b): Release from HM + 10% EALYS vs. HM + 2% EALYS.
2.4. Release of EA from Pectin Films under Simulated Gastrointestinal Conditions
To further explore the potential use of HM and LM pectin films for the controlled
release of EA under physiological conditions, both materials were subjected to simulated
gastrointestinal conditions following a reported protocol [15,26,27]. A limited amount of
EA, ranging from ca. 0.2 to 0.7 µmol (25–66 µM concentration, corresponding to 4–12% of
the overall EA content), was released after the first incubation at gastric pH, whereas higher
quantities, up to 3.6 µmol in the case of the HM pectin film (ca. 300 µM concentration,
corresponding to 64% of the overall content), were measured after 2 h incubation at the
slightly alkaline pH, simulating the small intestine environment (Figure 6). Notably, a less
efficient release of EA, especially at intestinal pH, was observed in the absence of enzymes
or bile salts. This would suggest that EA release is controlled not only by the different
solubility properties of the compound at the acidic and neutral pH mimicking the stomach
and intestinal environment, respectively, but also by interactions of the phenol with the
pectin polymeric network. These latter were significantly affected by the digestive enzymes
and bile salts, resulting in a weakening of the EALYS and pectin interactions and hence in
a higher release of EA.
Figure 6. Concentration of EA released under simulated gastrointestinal digestion from pectin films.
Reported are the mean ± SD values of three experiments. Different letters indicate statistically
significant differences (p < 0.05).
2.5. Prebiotic Activity of EALYS-Containing Pectin Films
It is well known that non-starch polysaccharides such as pectins may exert beneficial
effects on human health, preventing the onset of inflammatory bowel disease and related
pathologies by modulation of gut microbiota activity [28–30]. This generally results in
an increase in the production of short chain fatty acids (SCFAs), whose healthy proper-
ties, e.g., immunomodulation, are well established [31]. The same has been reported for
dietary phenolic compounds, including EA [32,33]. On this basis, the prebiotic activity
of the EALYS pectin films was evaluated by determination of changes in production of
SCFAs following microbial fermentation. Table 1 shows the levels of acetic, propionic, and
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butyric acids released after fermentation of the EALYS-loaded pectin films compared with
those produced by the control films and a blank sample (fermentative medium only). As
expected, fermentation of all the pectin films released higher amounts of SCFAs compared
with the blank sample (except for neat LM pectin films in the case of acetic acid), but
these were invariably higher when EALYS was present. Moreover, an increased prebiotic
activity was observed for HM pectin films with respect to LM films, except for butyric acid
production. These findings open the way toward a systematic evaluation of EA pectin
films for application in human health, e.g., as food supplements.
Table 1. Prebiotic activity of pectin films measured as release of short chain fatty acids (SCFAs) (mmol/g of sample) 1,2.
Sample Acetic Acid Propionic Acid Butyric Acid
HM Pectin + 10% EALYS 4.37 ± 0.09 a 3.01 ± 0.06 a 0.300 ± 0.007 a
HM Pectin 3.89 ± 0.08 b 2.06 ± 0.05 b 0.220 ± 0.006 b
LM Pectin + 10% EALYS 4.0 ± 0.1 b 2.83 ± 0.09 c 0.44 ± 0.02 c
LM Pectin 2.89 ± 0.06 c 1.73 ± 0.03 d 0.280 ± 0.009 d
Blank 1.01 ± 0.02 d 0.94 ± 0.02 e -
1 Reported are the mean ± SD values of three experiments. 2 Different letters indicate statistically significant differences (p < 0.05).
3. Materials and Methods
3.1. Reagents
Two types of pectins were purchased from Sigma-Aldrich (Schnelldorf, Germany):
pectin from apple (Poly-D-galacturonic acid methyl ester), having a degree of esterification
between 50% and 75%; and pectin from citrus peel, having a degree of esterification higher
than 67%. Calcium chloride anhydrous (≥99.9%, 40 mesh) and disodium hydrogen phos-
phate (anhydrous, ≥98.0%) were purchased from Merck (Darmstadt, Germany). Ellagic
acid (≥96.0%) and L-lysine (crystallized, ≥98.0%) were purchased from Fluka (Buchs,
Switzerland). Pepsin, pancreatin, bile salts, peptone water, and resazurin were purchased
from Sigma-Aldrich (Schnelldorf, Germany). Distilled water served as the solvent for
preparing film solutions.
3.2. Liquid Chromatography
HPLC analysis of EA during in vitro digestion was run on an Agilent 1100 Series
instrument using a reverse phase Phenomenex Sphereclone 250 × 4.60 mm column (par-
ticle size 5 µm). A gradient elution at a flow rate of 0.7 mL/min was performed using
0.1% formic acid in water (eluant A) and methanol (eluant B): 5% B, 0–10 min; 5–80% B
(10–45 min); detection wavelength was fixed at 254 nm.
Short chain fatty acids (SCFAs) determination was carried out on an Accela 600 HPLC
(Thermo Scientific, Munich, Germany) equipped with a pump, an autosampler, and a
UV–VIS PDA detector set at 210 nm; the mobile phase used was 0.1 M phosphate buffer
(pH 2.8)/acetonitrile 99:1 v/v delivered at a 1 mL/min flow rate; the column used was an
Aquasil C18 reversed phase (Thermo Scientific, Munich, Germany) (150 × 4.6 mm, 5 µm),
with a total run time of 20 min.
3.3. Ellagic Acid–Lysine Salt (EALYS) Preparation
EA (0.498 g, 1.65 mmol) and L-lysine (molar ratio of 1:1, 1:2, 1:3, and 1:4 on EA) were
weighted in a 100 mL round bottom flask and solubilized in 20 mL of distilled water under
magnetic stirring at room temperature. After 30 min, water was removed under vacuum at
50 ◦C using a rotary evaporator until a wet powder was obtained. Residual water was then
removed under high vacuum (2 × 10−2 kPa) for 10 h at room temperature.
Each EALYS salt (20 mg) was weighted in a 15 mL glass vials and aliquots of 0.1 mL
of Chromasolv water was added under magnetic stirring at room temperature (20 ◦C) until
a homogeneous solution was obtained. Solubility of the salts are shown in Table 2. In the
case of EALYS 1:1, 1:2, and 1:3 salts, the salt was still visible after the addition of 15 mL
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of water; the sample was then centrifuged, and water was removed with a pipette. The
wet salt was then dried under high vacuum (2 × 10−2 kPa) for 10 h at room temperature
and weighted to check that the residual weight that resulted was almost identical to the
initial one.
Table 2. Water solubility of EALYS salts.





1:1 20.1 15 Insoluble —— ——
1:2 23.6 15 Insoluble —— ——
1:3 19.8 15 Insoluble —— ——
1:4 22.4 1.7 12.99 0.31 8.95
3.4. H-Nuclear Magnetic Resonance (1H-NMR)
The NMR spectrum of EALYS 1:4 was recorded using a Bruker 400 MHz NMR on
10 mg of EALYS 1:4 dissolved in 1 mL of deuterium oxide (D2O). 1H-NMR (400 MHz, D2O):
δ 7.13 (1H, s), 3.58 (2H, t, J = 6 Hz), 2.90 (4H, t, J = 8 Hz), 1.75 (4H, m), 1.60 (4H, dd, J = 8,
6 Hz), 1.35 (4H, m).
3.5. Solubility in CaCl2 Water Solution and in Phosphate Buffer Solution (PBS)
The solubility of EALYS 1:4 in CaCl2 solution and in phosphate buffer saline (PBS) was
estimated via UV analysis against a calibration curve built using EALYS water solutions,
setting the wavelength at 280 nm. A Jasco V-630 spectrophotometer was used. EALYS
(22.5 mg) was weighted in a 100 mL volumetric flask and solubilized in water. Twenty
mL of this solution was transferred in a 100 mL volumetric flask, which was filled with
Chromasolv water (Sol A). Sol A was then diluted to obtain a total of 5 solutions having
different concentrations of EALYS 1:4 salt.
EALYS 1:4 (12 mg) and CaCl2 (8 mg) were weighted in a 100 mL conic flask and
dissolved in 50 mL of water. The flask was taken in a water shaking bath for 60 min at
37 ◦C, then filtered using a syringe equipped with a 0.45 µm Teflon filter, and the resulting
solution was analyzed. Samples were prepared in triplicate in order to validate the results.
EALYS 1:4 (200 mg) was weighted in a 100 mL conic flask and dissolved in 50 mL of
PBS. The flask was taken in a water shaking bath for 60 min at 37 ◦C, then filtered using
a syringe equipped with a 0.45 µm Teflon filter, and the resulting solution was analyzed.
Samples were prepared in triplicate in order to validate the results.
3.6. Determination of Degree of Esterification (DE) of Pectins
The DE of pectins was determined according to the method developed by Manrique
et al. [25] using a Spectrum 100 spectrophotometer (Perkin Elmer) in attenuated total
reflection (ATR) mode using a resolution of 4.0 and 256 scans in a range of wavenumber
between 4000 cm−1 and 400 cm−1. A single-bounce diamond crystal was used with an
incidence angle of 45◦.
Pectin was dissolved in water (concentration of 5 g/L) under magnetic stirring at
room temperature overnight; then the pH was adjusted at 6.0 using 1 M KOH. Water was
removed by freeze-drying in order to obtain solid powders that were then analyzed.
3.7. Pectin Gels Preparation and Casting
Pectin gels were prepared following the procedure described by Fu et al. [34] and
Tibbits et al. [35] using CaCl2. For each pectin, several samples were prepared using
concentrations of pectin of 3 g/L, 5 g/L, 7.5 g/L, 10 g/L, 20 g/L, 30 g/L, and 40 g/L. In
brief, pectin was weighted in a 100 mL round bottom flask and dissolved in 0.1 M NaCl
water solution under magnetic stirring overnight. The pH was then adjusted to between
6.5 and 7.0 by using 1 M KOH water solution and the solution was mechanically stirred at
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80 ◦C for 15 min. Solid CaCl2 was added, keeping the solution under mechanical stirring
for 10 min at 80 ◦C in order to obtain a homogenous solution. The solution was then left at
room temperature for 48 h in order to complete the gelling process.
The amount of CaCl2 required for the gelling process was calculated based on the DE









where R = 0.58 is a predetermined parameter already used in the procedure described
in literature [34], [COO−] is the concentration on carboxylic acid moieties (determined
knowing the DE) and [Ca2+] is calcium ion concentration.
3.8. EALYS Pectin Gels Preparation and Casting
A procedure close to procedure described in 3.9 was used for the preparation of pectin
gels with EALYS 1:4. LM or HM pectin was weighted in a 100 mL round bottom flask
and dissolved in 0.1 M NaCl water solution (30 g/L final concentration) under magnetic
stirring overnight. The pH was adjusted to between 6.5 and 7.0 by using 1 M KOH, and
then EALYS 1:4 was added (10% w/w on the solution). The solution was mechanically
stirred for 10 min, then the temperature was raised to 80 ◦C for 15 min. Solid CaCl2 was
added, keeping the solution under mechanical stirring for 10 min at 80 ◦C in order to obtain
a homogenous solution. When gelification was required, the solution was left at room
temperature for 48 h in a closed flask in order to complete the gelling process.
Pectin films were directly obtained by solvent casting deposition without waiting the
48 h indicated above, pouring 50 mL of a 30 g/L solution of pectin into a plastic Petri dish
having 8.5 cm of diameter and 1 cm of depth. The film was obtained by solvent evaporation
after 72 h under suction hood.
3.9. Rheological Analyses
Rheological analyses, conducted using frequency sweep experiments, were performed
with a Physica MCR 300 rotational rheometer with a parallel plate geometry (Φ = 50 mm,
distance between plates = 1 mm). Linear viscoelastic regimes of neat pectin gel and pectin
gel loaded with EALYS were studied; strain was set equal to 3% and curves of complex
viscosity as a function of frequency were recorded, taking 30 points ranging from 0.01 Hz
to 20 Hz with a logarithmic progression, at 25 ◦C; in this paper, shear rate but not angular
frequency is reported on the x-axis.
3.10. Release Experiments
EALYS pectin films (10–30 mg) were weighed in a 15 mL flat bottom vial and dispersed
in phosphate buffered solution (PBS) at pH 7.4 (10 mL). The release assay was developed
in a time range of 24 h by analyzing the samples at 15, 30, 45, 60, 120 min, and 24 h. Each
sample was prepared in triplicate. The vials were placed in a horizontal water shaking
bath (Dubnoff) set at 37 ◦C with a shaking ratio of 90 strokes per minute. At the fixed time,
three samples were removed from bath, hand-shaken in order to obtain a homogeneous
solution, and filtered using a syringe equipped with a 0.45 µm Teflon filter. The filtered
solutions were analyzed by using a UV-VIS spectrophotometer in order to evaluate the
quantity of EALYS released from pectin film.
3.11. In Vitro Digestion
A previously reported procedure was adopted [15,26,27]. Briefly, pectin films (50 mg)
containing 10% w/w EALYS 1:4 were added to 10 mL of distilled water preliminarily
adjusted to pH 2 with 1 M HCl. Added was 315 U/mL pepsin, and the mixture was
incubated at 37 ◦C under stirring in the dark. After 2 h, 1 mL of solution was withdrawn
and analyzed for EA by HPLC. To the remaining mixture, 9 mg of pancreatin and 56 mg of
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bile salts dissolved in 2.2 mL of 0.1 M NaHCO3 were added, followed by 0.8 mL of 1 M
NaHCO3. After 2 h of incubation at 37 ◦C under stirring in the dark, the solution was
again analyzed by HPLC. In order to stop the reaction, the mixture was then centrifuged
at 14,000 rpm for 10 min at 4 ◦C. After separating the solid from the liquid fraction,
10% of this latter (1.2 mL) was added to the solid fraction, and this combined material was
lyophilized. The lyophilized sample, mimicking the fraction that is not readily absorbed
after digestion, was then subjected to the in vitro fermentation as described in Section 3.12.
Control experiments were run exposing pectin films to the same pH conditions but without
the addition of the enzyme components and bile salts.
3.12. In Vitro Fermentation and SCFAs Analysis
A previously described protocol was used [36]. In brief, to 50 mg of lyophilized
digestion solid residue, 3 mL of distilled water was added into a screw-cap tube. Then,
1.25 mL of fermentation final solution (peptone water + resazurine) was added, followed by
0.33 mL of inoculum, consisting of a 32% feces solution in 0.1 M phosphate buffer (pH 7.0)
(fecal content composed of a mixture of equal weight of fresh morning feces of three healthy
adult human donors). Nitrogen was bubbled in order to reach an anaerobic atmosphere,
and the mixture was incubated at 37 ◦C for 20 h under oscillation. The samples were then
buried in ice to stop microbial activity and centrifuged, filtered through a 0.22 µm nylon
filter, and finally analyzed for SCFAs (acetic, propionic, and butyric acid) by HPLC. A
calibration curve was used for quantitation. Control samples not containing pectin films
were also analyzed.
4. Conclusions
The use of pectins, an easily accessible low-cost class of heteropolysaccharides, as
matrices to deliver bioactive compounds represents a green approach that has been increas-
ingly pursued in the biomedical and nutraceutical fields since these soluble non-starch
polysaccaharides meet most regulations for use in humans.
The results of this study highlight the good performance of pectins at low and high
esterification degrees as systems for the controlled release of EA. The possibility that EA
may be selectively released and absorbed in the intestinal tract after passing the gastric
compartments was preliminarily demonstrated by use of a simulated gastric intestinal
digestion model, suggesting that oral administration of EA may be conceived using such
formulations. Degradation of the pectin network by the intestine enzymatic systems as sug-
gested by our data may further aid the release. The concentrations reached particularly for
HM pectin films may be reasonably near to the doses needed for bioactivity. Furthermore,
the slight but significant prebiotic activity shown by the EALYS pectin films contribute
to define the beneficial profile of the formulations presented. Further assessment of their
properties on in vitro cellular systems and in vivo models represents a highly desirable
perspective opened by this proof of concept study.
Supplementary Materials: The following are available online, Figure S1: Rheological analysis of
30 g/L LM pectin gels after 48 h and after 168 h. Figure S2: Rheological analysis of 30 g/L LM pectin
gels loaded with EALYS after 48 h and after 168 h. Figure S3: Rheological analysis of 40 g/L HM
pectin gels and of 40 g/L HM pectin gels loaded with EALYS.
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